CIA
Citizens, Inc.
CIA's fundamentals are mixed, but it looks expensive: trading at 23x earnings, above its usual 16x. Analysts expect earnings to decline.
IREN
IREN Limited
There isn't enough reported data to score IREN yet.
CIA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| N/A | |
| N/A |
CIA's revenue and profitability are currently stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like CIA.
IREN Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| N/A | |
| N/A |
IREN's revenue and profitability are currently under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like IREN.
CIA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 6.9x | $1.10 | -70% |
| Fair | 16x | $2.60 | -29% |
| Forward | 19x | $3.67 | — |
| Current | 23x | $3.67 | — |
| Expensive | 24x | $3.86 | +5.1% |
Historical ranges are pointers, not guarantees.
CIA's PE is in its expensive range at 23x. On analysts' estimates for next year's earnings, today's price would be 19x, in its fair range.
IREN PE Valuation
IREN has no meaningful PE right now: it lost money over the past year.
CIA Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Decline | |
| Stable | |
| Weakening | |
| Limited | |
| High |
Analysts expect CIA's earnings and profitability to decline, with its revenue holding steady.
IREN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
IREN has the edge over CIA on the outlook, with more favorable revenue and profitability expectations.
CIA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.19 | +19% |
| Q3 2026 | $0.16 | -24% |
| Q2 2026 | $0.21 | -4.5% |
| Q1 2026 | $0.35 | +106% |
| Q4 2025 | $0.28 | -3.4% |
| Q3 2025 | $0.21 | -51% |
| Q2 2025 | $0.22 | -49% |
| Q1 2025 | $0.17 | -64% |
| Q4 2024 | $0.29 | -40% |
CIA has the edge over IREN on earnings quality, reporting a profit while its opponent remains loss making.
IREN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$3.96 | -347% |
| Q2 2026 | -$2.22 | -988% |
| Q1 2026 | $0.51 | +$1.10 |
| Q4 2025 | $1.18 | +$1.62 |
| Q3 2025 | $1.60 | +$1.99 |
| Q2 2025 | $0.25 | +$0.45 |
| Q1 2025 | -$0.59 | -$0.43 |
| Q4 2024 | -$0.44 | -$0.15 |
IREN has swung to a loss: it lost $3.96 per share over the past year, after a profit the year before.
CIA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $65M | +3.6% |
| Q2 2026 | $60.4M | -7.2% |
| Q1 2026 | $59.7M | +7.3% |
| Q4 2025 | $72.1M | +14% |
| Q3 2025 | $62.8M | +1.7% |
| Q2 2025 | $65.1M | +4.8% |
| Q1 2025 | $55.7M | -3.6% |
| Q4 2024 | $63.5M | -5% |
CIA's revenue has picked up after four years of holding roughly level: $65M last quarter, up 3.6% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 0.2% | -6.9 points |
| Q2 2026 | -0.9% | -12 points |
| Q1 2026 | 4% | +7.2 points |
| Q4 2025 | 11% | +5.1 points |
| Q3 2025 | 7.1% | +2.2 points |
| Q2 2025 | 11% | +5.3 points |
| Q1 2025 | -3.2% | -12 points |
| Q4 2024 | 5.8% | -7.3 points |
CIA has the edge over IREN on profitability, with a higher operating margin.
IREN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $228M | -5.1% |
| Q2 2026 | $137.2M | -27% |
| Q1 2026 | $144.8M | 0% |
| Q4 2025 | $184.7M | +59% |
| Q3 2025 | $240.3M | +355% |
| Q2 2025 | $187.3M | +230% |
| Q1 2025 | $144.8M | +168% |
| Q4 2024 | $116.1M | +176% |
IREN has the edge over CIA on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -82% | -50 points |
| Q2 2026 | -452% | -461 points |
| Q1 2026 | -161% | -180 points |
| Q4 2025 | -63% | -79 points |
| Q3 2025 | -32% | +57 points |
| Q2 2025 | 9% | +49 points |
| Q1 2025 | 19% | +8 points |
| Q4 2024 | 15% | +21 points |
IREN's operating margin was −82% last quarter, down 50 points from the same quarter a year ago.
CIA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $10.7M | +132% |
| Q2 2026 | $2M | -39% |
| Q1 2026 | -$649K | -201% |
| Q4 2025 | $9M | -16% |
| Q3 2025 | $4.6M | -51% |
| Q2 2025 | $3.3M | -26% |
| Q1 2025 | $641K | -90% |
| Q4 2024 | $10.7M | +66% |
CIA has the edge over IREN on cash generation, producing positive trailing cash flow while its opponent burns cash.
IREN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.6B | -$1.6B |
| Q2 2026 | $482.2M | +2895% |
| Q1 2026 | -$873.8M | -$523.1M |
| Q4 2025 | -$468M | -$334M |
| Q3 2025 | -$38M | +$349.4M |
| Q2 2025 | $16.1M | +$179M |
| Q1 2025 | -$350.7M | -$128.7M |
| Q4 2024 | -$134M | -$105.2M |
IREN's free cash flow was −$2.5B over the past year, against −$507M the year before. Free cash flow isn't a meaningful measure for financial services companies like IREN.
CIA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +61.7K shares |
| 1 year | +0.8% | +408K shares |
| 3 years | +2.3% | +1.2M shares |
| 5 years | +0.5% | +248K shares |
CIA has the edge over IREN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2024 | — |
| Q3 2024 | — |
| Q4 2023 | $200,000 |
| Q3 2023 | — |
| Q1 2023 | — |
| Q4 2022 | $522,000 |
| Q4 2021 | — |
| Q3 2021 | — |
IREN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +26% | +82.4M shares |
| 1 year | +10% | +36.9M shares |
| 3 years | +511% | +333M shares |
| 5 years | +624% | +344M shares |
| Available history | +2346% | +382M shares |
IREN has 399M diluted shares, up 10% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
CIA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.7x | Net Cash |
| Q2 2026 | -1.1x | Net Cash |
| Q1 2026 | -0.8x | Net Cash |
| Q4 2025 | -1.3x | Net Cash |
| Q3 2025 | -1.7x | Net Cash |
| Q2 2025 | -1.8x | Net Cash |
| Q1 2025 | -2.1x | Net Cash |
| Q4 2024 | -1.9x | Net Cash |
CIA has more cash than debt. Net leverage isn't a meaningful measure for financial services companies like CIA.
IREN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | 157.6x | High |
| Q4 2025 | 22.2x | High |
| Q3 2025 | 4.1x | High |
| Q2 2025 | 2.0x | Moderate |
| Q1 2025 | 3.3x | Elevated |
| Q4 2024 | -4.6x | Net Cash |
| Q3 2024 | -16.7x | Net Cash |
| Q2 2024 | -15.9x | Net Cash |
IREN's net debt is more than 20 years of its operating earnings (EBITDA), up from 3.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like IREN.
CIA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.7 | Neutral |
| Stochastic | 32.8 | Neutral |
CIA's weekly RSI is 41 (neutral) and its Stochastic is 33 (neutral).
IREN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.3 | Neutral |
| Stochastic | 8.2 | Oversold |
IREN's weekly RSI is 33 (neutral) and its Stochastic is 8 (oversold).
CIA PE vs Financial Services Sector
| Metric | CIA | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 13x | 76% above |
| PE % | 76 | 63 | 13 pts above |
CIA is trading at 23x earnings, a 76% premium to the Financial Services sector's median of 13x.
IREN PE vs Financial Services Sector
| Metric | IREN | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
IREN has no meaningful PE right now: it lost money over the past year.
CIA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.63 | 1.1% above |
| 20 week MA | $4.10 | 10% below |
| 50 week MA | $4.85 | 24% below |
| 100 week MA | $4.76 | 23% below |
| 200 week MA | $3.85 | 4.7% below |
CIA has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 4.7% below its 200-week average.
IREN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.8 | 35% below |
| 20 week MA | $36.2 | 46% below |
| 50 week MA | $42.8 | 54% below |
| 100 week MA | $32.0 | 39% below |
| 200 week MA | $19.1 | 2.1% above |
IREN has fallen below most of its moving averages, though it's still 2.1% above its 200-week average.
CIA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $6.67 | $5.89 | -12% |
| 2021 | $5.89 | $5.76 | -2.2% |
| 2022 | $5.76 | $2.28 | -60% |
| 2023 | $2.28 | $2.69 | +18% |
| 2024 | $2.69 | $4.32 | +61% |
| 2025 | $4.32 | $5.16 | +19% |
| 2026 YTD | $5.16 | $3.67 | -29% |
CIA has the edge over IREN on returns for 2026, with the stronger performance.
IREN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $24.8 | $17.2 | -31% |
| 2022 | $17.2 | $1.19 | -93% |
| 2023 | $1.19 | $7.15 | +501% |
| 2024 | $7.15 | $10.7 | +50% |
| 2025 | $10.7 | $40.3 | +276% |
| 2026 YTD | $40.3 | $19.5 | -52% |
IREN's yearly returns have swung widely, from +501% in 2023 to −93% in 2022. It's down 52% so far in 2026.